23 results for "Paul Pfeffer"
Showing 1–20 · 0.69 seconds · RSS
-
-
Journal Article
Understanding interventions delivered in the emergency department targeting improved asthma outcomes beyond the emergency department: an integrative review
Objectives The emergency department (ED) represents a place and moment of opportunity to provide interventions to improve long-term asthma outcomes, but feasibility, effectiveness and mechanisms of impact are poorly understood. We aimed to review the existing literature on interventions that are…
-
Journal Article
Characteristics of patients with asthma overprescribed short-acting beta-agonist (SABA) reliever inhalers stratified by blood eosinophil count in North East London: a cross-sectional observational study
Background: Overprescription of short-acting beta-agonist (SABA) inhalers and blood eosinophil count have strong associations with exacerbation risk in asthma. However, in the authors' recent publication only a minority of patients overprescribed SABA (≥6 inhalers in 12 months) were eosinophilic…
-
Journal Article
Reducing short-acting beta-agonist overprescribing in general practice: Evaluation of a quality improvement programme in East London
Background Overprescribing of short-acting beta-agonist (SABA) inhalers is a worldwide problem.Objectives To evaluate the impact of a system-wide quality improvement programme on SABA overprescribing, and to identify the most effective strategies.Methods All general practices within one East London…
-
Journal Article
Trajectories of functional limitations, health-related quality of life and societal costs in individuals with long COVID: a population-based longitudinal cohort study
Objectives To examine trajectories of functional limitations, fatigue, health-related quality of life (HRQL) and societal costs of patients referred to long COVID clinics.Design A population-based longitudinal cohort study using real-time user data.Setting 35 specialised long COVID clinics in the…
-
Journal Article
Lessons learned from a UK platform trial during the COVID-19 pandemic and beyond: The BEAT-Severe Asthma Trial
Background It is estimated that around 5% of people with asthma have severe asthma. Severe asthma typically presents with poor symptom control, impaired lung function and asthma exacerbations, despite regular inhaled steroids and additional controller medications. In the BEyond Allergic Th2-Severe…
-
Journal Article
Using normalisation process theory to evaluate the implementation of a digital health intervention in community and secondary care long COVID clinics
Objectives The potential and expected benefits of digital health interventions (DHI) have long been discussed, yet substantial challenges are associated with deploying DHI at scale. Insights are presented concerning the implementation of a DHI consisting of a patient-facing app and a digital…
-
Journal Article Full text
An examination of factorial invariance of the Asthma Control Questionnaire among adults with severe asthma
Background: The Asthma Control Questionnaire (ACQ) is used to assess asthma symptom control. The relationship between the questionnaire items and symptom control has not been fully studied in severe asthmatic patients, and its validity for making comparisons between subgroups of patients is…
-
Journal Article
Development and implementation of a digital health intervention in routine care for long COVID patients: a comprehensive synopsis
Background By July 2020, large numbers of post-COVID patients were experiencing symptoms for weeks or months, but traditional National Health Service models of rehabilitation service delivery could not meet demand. Objectives Design and deploy a digital health intervention to provide digitally…
-
Journal Article
Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis
Persistent breathlessness >28 days after acute COVID-19 infection has been identified as a highly debilitating post-COVID symptom. However, the prevalence, risk factors, mechanisms and treatments for post-COVID breathlessness remain poorly understood. We systematically searched PubMed and Embase…
-
Journal Article
Adverse outcomes in young adults with severe asthma: results from the UK Severe Asthma Registry
Background Chronic disease in young adults is associated with poor healthcare engagement, poor health-related outcomes and high-risk behaviours. However, there are minimal data regarding the outcomes of young adults with severe asthma. In this study we aimed to assess asthma characteristics and…
-
Journal Article
Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study
Objectives To describe self-reported characteristics and symptoms of treatment-seeking patients with post-COVID-19 syndrome (PCS). To assess the impact of symptoms on health-related quality of life (HRQoL) and patients’ ability to work and undertake activities of daily living.Design Cross-sectional…
-
Journal Article
Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures
Deep sequencing of B cell receptor (BCR) heavy chains from a cohort of 31 COVID-19 patients from the UK reveals a stereotypical naive immune response to SARS-CoV-2 which is consistent across patients. Clonal expansion of the B cell population is also observed and may be the result of memory…
-
Journal Article Full text
Eosinophilic and Noneosinophilic Asthma
Background Phenotypic characteristics of patients with eosinophilic and noneosinophilic asthma are not well characterized in global, real-life severe asthma cohorts. Research Question What is the prevalence of eosinophilic and noneosinophilic phenotypes in the population with severe asthma, and can…
-
Journal Article
Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19
Background Persistence of respiratory symptoms, particularly breathlessness, after acute coronavirus disease 2019 (COVID-19) infection has emerged as a significant clinical problem. We aimed to characterise and identify risk factors for patients with persistent breathlessness following COVID-19…
-
Journal Article
Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses
Passive immunization using monoclonal antibodies will play a vital role in the fight against COVID-19. The recent emergence of viral variants with reduced sensitivity to some current antibodies and vaccines highlights the importance of broad cross-reactivity. This study describes deep-mining of the…
-
Journal Article Full text
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
BACKGROUND: No effective pharmacological or non-pharmacological interventions exist for patients with long COVID. We aimed to describe recovery 1 year after hospital discharge for COVID-19, identify factors associated with patient-perceived recovery, and identify potential therapeutic targets by…